|
|
Latest Gastric Cancer News
Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (7/16/2010)
Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation.
High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (7/12/2010)
High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma.
Depression May Persist With Metastatic Cancer (5/27/2010)
A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.
Genetic Variant Associated with Poor Outcome for Gastric Cancer (5/24/2010)
Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the genetic variation (seven years), according to the results of a study presented at the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida.
Adjuvant Chemotherapy Clinical Trial Data from Last 30 Years Evaluated to Determine Benefit in Gastric Cancer (5/14/2010)
A moderate but statistically significant survival benefit was reported with the addition of chemotherapy to surgery in patients with resectable gastric cancer (gastric cancer that can be surgically removed). These findings were recently published in the Journal of the American Medical Association.
Gastric Cancer News By Topic
Gastric Cancer - Screening/PreventionHigh Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (7/12/2010)
High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma.
Cancers of the Lower Stomach have Increased in Young Whites (5/7/2010)
Although overall rates of noncardia gastric cancer (cancer of the lower stomach) have decreased in the United States, rates have increased in whites between the ages of 25 and 39 years. These findings were recently published in the Journal of the American Medical Association.
Aspirin May Reduce Risk of Stomach Cancer (8/28/2009)
Regular aspirin use may reduce the risk of distal stomach cancer (cancer in the lower part of the stomach). These results were published in the American Journal of Epidemiology.
Fruits and Vegetables Reduce Risk of Stomach Cancer (2/1/2008)
According to an article recently published in the American Journal of Epidemiology, diets higher in vegetables and fruits and lower in foods common in Western diets (such as processed meats, soft drinks, and sugars) can significantly reduce the risk of developing stomach cancer.
Epstein-Barr Virus Not Associated with Gastric Cancer (11/29/2007)
According to an article recently published in the British Journal of Cancer, individuals infected with the Epstein-Barr virus (EBV) do not have an increased risk of gastric cancer.
Gastric Cancer - Stages I-IIGenetic Variant Associated with Poor Outcome for Gastric Cancer (5/24/2010)
Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the genetic variation (seven years), according to the results of a study presented at the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida.
Adjuvant Chemotherapy Clinical Trial Data from Last 30 Years Evaluated to Determine Benefit in Gastric Cancer (5/14/2010)
A moderate but statistically significant survival benefit was reported with the addition of chemotherapy to surgery in patients with resectable gastric cancer (gastric cancer that can be surgically removed). These findings were recently published in the Journal of the American Medical Association.
Laparoscopic Surgery Results in Fewer Complications for Patients with Stomach Cancer (5/8/2009)
Laparoscopic surgery produces a similar rate of recurrence-free survival as traditional open surgery in patients with gastric cancer but results in fewer complications and shorter hospital stays, according to the results of a study published in the Annals of Surgical Oncology.
In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer (8/4/2008)
Among patients diagnosed with gastric (stomach) cancer, a combination of antibiotics against the bacterium Helicobacter pylori (H. pylori) significantly reduces the risk of developing a second gastric cancer. These results were recently published in the August 2008 issue of Lancet Oncology.
Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers (7/23/2008)
Researchers recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. These results were recently published in the Archives of Surgery.
Gastric Cancer - Stages III-IVClinical Trial for Advanced Gastric Cancer Now Enrolling Patients (7/16/2010)
Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation.
Depression May Persist With Metastatic Cancer (5/27/2010)
A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.
Avastin Fails to Prolong Survival in Stomach Cancer (2/25/2010)
Avastin® (bevacizumab) in combination with chemotherapy does not extend overall survival in patients with inoperable, advanced or metastatic stomach cancer, according to the results of a phase III trial released by Roche.
Herceptin® Improves Outcome of HER2-positive Stomach Cancer (9/25/2009)
According to the results of a Phase III clinical trial, treatment with the targeted therapy Herceptin® (trastuzumab) improves survival among patients with HER2-positive, advanced and inoperable stomach cancer. These results were presented at a major European cancer conference.
Herceptin® Improves Survival with HER2-positive Gastric Cancer (6/2/2009)
According to the results of a Phase III clinical trial presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), treatment with a combination of chemotherapy and the targeted drug Herceptin® (trastuzumab) results in better survival than chemotherapy alone among patients with advanced, HER2-positive gastric (stomach) cancer.
Gastric Cancer - RecurrentClinical Trial for Advanced Gastric Cancer Now Enrolling Patients (7/16/2010)
Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation.
Herceptin® Improves Survival with HER2-positive Gastric Cancer (6/2/2009)
According to the results of a Phase III clinical trial presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), treatment with a combination of chemotherapy and the targeted drug Herceptin® (trastuzumab) results in better survival than chemotherapy alone among patients with advanced, HER2-positive gastric (stomach) cancer.
Increased Doses of Gleevec® for Gleevec-Resistant Gastrointestinal Stromal Tumors (GIST) Effective (8/17/2005)
According to a recent article published in the European Journal of Cancer, increasing doses of Gleevec® (imatinib) provides anti-cancer activity in patients diagnosed with Gastrointestinal Stromal Tumors (GIST) that had stopped responding to lower doses of the drug.
Lab Test Shows Promise for Detecting Gastric Cancer Recurrence (2/8/2005)
A recent study in the American Journal of Clinical Oncology reports that a lab test analyzing a cancer marker known as carcinoembryonic antigen (CEA) may be useful in identifying patients who may be at risk for recurrence of gastric cancer.
Mortality from Some Cancer Surgeries Reduced in Large-Volume Hospitals (4/15/2002)
According to a recent article published in
The New England Journal of Medicine, death related to surgical procedures (surgical mortality) for some cancers may be significantly reduced if patients receive treatment in hospitals that perform large volumes of the surgical procedure annually.
|
|
